Portfolio Vice President Novo Nordisk New Brunswick, New Jersey
Join Otilia Koo and several authors in Poster Forum #8 in the Solution Center for a conversation about posters on the topic, “A Showcase of the Comprehensive Science from AAPS in Advancing Pharmaceutical Development”, that she is especially excited about.
T1130-01-02 Application of Knowledge Based Expert System to Predict API-Excipient Incompatibilities, Koyel Sen, Ph.D., Boehringer Ingelheim Pharmaceuticals, Inc.
T1030-11-60 Challenges with Removal and Addition of Polysorbates From/To Formulations of Monoclonal Antibodies, Hesham Abdelsamad, MSc, University of Iowa
M0930-02-07 Comparative Analysis of Pharmacokinetics and Drug-Drug Interactions in Microdosing Cocktail Studies Using Physiologically-Based Pharmacokinetic Modeling, Jesse Yang, MS, Gilead Sciences, Inc.
W0930-02-10 Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers, Amita Datta-Mannan, Ph.D., Eli Lilly and Company
M1430-05-25 Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions, Dongyue Yu, Ph.D., Bristol-Myers Squibb Company
